These small proteins target metabolism, hunger, and fat loss, offering new hope for those who need extra support on their weight loss journey
This latest approval for Wegovy simply allows doctors to formally expand treatment to a larger group of people: those with overweight or obesity who have cardiovascular disease but not diabetes
Genetic Factors in Weight and Gut Response Individual genetic variations influence how your body responds to GLP-1 medications and how your gut processes food
While this class of medications is generally considered safe and effective, potentially severe neurological complications may be associated with rapid weight loss and nutritional deficiencies following GLP-1 agonist use
Understanding Ozempic: How does it work
Full results aren't available yet, but Novo Nordisk said there was a "statistically significant" 0.83% reduction in A1c levels with semaglutide compared to placebo at that time point